Page last updated: 2024-12-10
allithiamine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
allithiamine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 12358373 |
SCHEMBL ID | 19533172 |
MeSH ID | M0059952 |
Synonyms (7)
Synonym |
---|
554-44-9 |
allithiamine |
thiamin-allyl-disulfid |
n-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-n-[4-hydroxy-1-methyl-2-(2-propenyldithio)-1-butenyl]formamide, 9ci |
SCHEMBL19533172 |
n-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[5-hydroxy-3-(prop-2-enyldisulfanyl)pent-2-en-2-yl]formamide |
thiaminetetrahydrofurfuryldisulfide |
Research Excerpts
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
"Lipid-soluble thiamine precursors have a much higher bioavailability than genuine thiamine and therefore are more suitable for therapeutic purposes." | ( Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. Bettendorff, L; Evrard, B; Gangolf, M; Piette, M; Plumier, JC; Seyen, S; Volvert, ML, 2008) | 0.35 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (16)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 10 (62.50) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (12.50%) | 5.53% |
Reviews | 2 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (75.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |